- Home
- LRMR vs TWN Comparison
LRMR vs TWN Comparison
Compare LRMR & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- TWN
- Stock Information
- Founded
- LRMR N/A
- TWN 1986
- Country
- LRMR United States
- TWN Hong Kong
- Employees
- LRMR N/A
- TWN N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- TWN Trusts Except Educational Religious and Charitable
- Sector
- LRMR Health Care
- TWN Finance
- Exchange
- LRMR Nasdaq
- TWN Nasdaq
- Market Cap
- LRMR 191.4M
- TWN 193.5M
- IPO Year
- LRMR N/A
- TWN N/A
- Fundamental
- Price
- LRMR $3.09
- TWN $45.63
- Analyst Decision
- LRMR Strong Buy
- TWN
- Analyst Count
- LRMR 7
- TWN 0
- Target Price
- LRMR $17.86
- TWN N/A
- AVG Volume (30 Days)
- LRMR 1.4M
- TWN 20.1K
- Earning Date
- LRMR 08-06-2025
- TWN 01-01-0001
- Dividend Yield
- LRMR N/A
- TWN 1.10%
- EPS Growth
- LRMR N/A
- TWN N/A
- EPS
- LRMR N/A
- TWN N/A
- Revenue
- LRMR N/A
- TWN N/A
- Revenue This Year
- LRMR N/A
- TWN N/A
- Revenue Next Year
- LRMR N/A
- TWN N/A
- P/E Ratio
- LRMR N/A
- TWN N/A
- Revenue Growth
- LRMR N/A
- TWN N/A
- 52 Week Low
- LRMR $1.61
- TWN $25.22
- 52 Week High
- LRMR $11.20
- TWN $41.51
- Technical
- Relative Strength Index (RSI)
- LRMR 60.78
- TWN 82.35
- Support Level
- LRMR $2.81
- TWN $44.01
- Resistance Level
- LRMR $3.19
- TWN $44.70
- Average True Range (ATR)
- LRMR 0.30
- TWN 0.56
- MACD
- LRMR 0.01
- TWN 0.08
- Stochastic Oscillator
- LRMR 82.43
- TWN 100.00
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.